Tiffany L. Correll
Biogen (United States)(US)Amgen (United States)(US)
Publications by Year
Research Areas
Synthesis and biological activity, Extraction and Separation Processes, Melanoma and MAPK Pathways, Chemical Reactions and Isotopes, Phytochemicals and Antioxidant Activities
Most-Cited Works
- → Rational Design and Binding Mode Duality of MDM2–p53 Inhibitors(2013)84 cited
- → Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic Spirocycles(2013)81 cited
- → A highly enantioselective catalyst for asymmetric hydroformylation of [2.2.1]-bicyclic olefins(2005)56 cited
- → Fused Piperidines as a Novel Class of Potent and Orally Available Transient Receptor Potential Melastatin Type 8 (TRPM8) Antagonists(2012)55 cited
- → Development of a Commercial Manufacturing Process for Sotorasib, a First-in-Class KRASG12C Inhibitor(2022)30 cited
- → Development of a Practical Synthesis of a p38 MAP Kinase Inhibitor(2009)28 cited
- → Development of a Commercial Process To Prepare AMG 232 Using a Green Ozonolysis–Pinnick Tandem Transformation(2018)20 cited
- → Development of a Practical Synthesis of a Pyrazolopyridinone-Based p38 MAP Kinase Inhibitor(2010)19 cited
- → Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of Alzheimer’s disease(2013)15 cited
- → Development of a Factory Process for Omecamtiv Mecarbil, a Novel Cardiac Myosin Activator(2019)13 cited